Appointment booking for Dr. Amin Radparvar, MD is currently not available.Dr. Amin Radparvar, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Amin Radparvar, MD (he/him) is an Endocrinologist in St peters, MO with over 18 years of experience. What is your opinion of Dr. Amin Radparvar, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 18 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Amin Radparvar, MD has received over $3,945 which includes payments from the following companies:
$3,129.48 from Medtronic MiniMed, Inc.
$133.51 from Dexcom, Inc.
$101.62 from Abbott Laboratories
$78.32 from Valeritas, Inc.
$75.53 from INSULET CORPORATION
$74.26 from LILLY USA, LLC
$68.35 from Novo Nordisk Inc
$63.31 from sanofi-aventis U.S. LLC
$52.96 from Amarin Pharma Inc.
$36.86 from AKRIMAX PHARMACEUTICALS, LLC
$14.85 from MannKind Corporation
$14.74 from AstraZeneca Pharmaceuticals LP
$14.44 from Becton, Dickinson and Company
$14.25 from Merck Sharp & Dohme Corporation
$13.54 from Animas Corporation
$12.62 from Eisai Inc.
$12.51 from Amgen Inc.
$12.25 from Orexigen Therapeutics, Inc.
$12.19 from Janssen Pharmaceuticals, Inc
$10.19 from VIVUS, Inc.
Payments received by Dr. Amin Radparvar, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!